Careers

Diversity

With 17 offices, from New York to Los Angeles and Seattle to Orlando, we live and work in communities all over the U.S., collaborating across locations, disciplines and even borders. Our experienced, highly ranked lawyers serve businesses wherever they are and wherever they want to go.

Offices

About Us

Pages

Professionals

Thought leadership: blogs, podcasts, videos, publications, events and news

Insights

Services

Pro Bono

Am Law 100 firm with practices in Business, Digital Assets and Data Management, Intellectual Property, Labor & Employment, Litigation and Tax.

Home | BakerHostetler

July IP Litigation Newsletter

The Cloakroom with Peter Roskam

The Cloakroom with Peter Roskam: 2024 Republican National Convention

Elise Elam Moderates Panel at ACLI Compliance and Legal Sections Annual Meeting

James Sherer Speaks on Panel at The Masters Conference

<figure class="wp-block-image alignright size-large is-resized"><img decoding="async" src="https://healthlawupdate.bakerhostetlerblogs.com/wp-content/uploads/sites/19/2022/12/medicine-compounding-pharmacy-GettyImages-823870840_1200x630-1-640x336.jpg" alt="" class="wp-image-5233" width="428" /></figure>



<p>Former co-owner of the now defunct New England Compounding Center (NECC) Gregory Conigliaro may face prison time for conspiring to defraud the U.S. Food and Drug Administration (FDA). Prosecutors argued Conigliaro conspired with more than a dozen others at NECC to deceive and defraud the FDA by misrepresenting the facility as solely a compounding pharmacy dispensing only patient-specific prescriptions while in fact it was also operating as a generic drug manufacturer.</p>



<p><a href="https://www.bakerlaw.com/alerts/note-of-caution-to-compounding-pharmacies">Read the full Alert.</a></p>

core/freeform

Health Law Update

Note of Caution to Compounding Pharmacies

Featured Insights